Results per Page:
Guiding the attack: CXCR3 leads CAR T cells to pediatric brain tumors
From the Vitanza Lab, Seattle Children’s Research Institute, University of Washington and the Cancer Consortium
Following a surprising cancer diagnosis, a mother of two turned to experts at UW Medicine and Fred Hutch for care and proton therapy
She researched the pros and cons of protons and ultimately decided the therapy made the most sense.
Proton therapy helped treat grad student’s extensive meningioma
A multidisciplinary care approach at Fred Hutch supported Erin Bremmer’s treatment
New methods reveal cancer mechanism in ancient genes
Fred Hutch researchers discover that overproduction of DNA packaging material predicts aggressive brain and breast tumors, which could lead to cheaper diagnostic tests and new drug therapies
More to brain tumors than meets the eye
Fred Hutch researchers find new way to classify tumors based on their underlying biology rather than how they look
Localized delivery of CAR T cells to treat children with brain tumors
From the Paulovich Lab, Translational Science and Therapeutics Division and Nicholas Vitanza Seattle Children’s Research Institute
Innovative Holland Lab mouse model helps tease apart YAP1’s role in brain cancer
From the Holland Lab, Cancer Basic Biology Program, Cancer Consortium.
Cancer clinical trials exclude too many patients: That’s changing
Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials
Tip Sheet: Looking ahead to 2021, COVID-19 vaccines, improving health outcomes — and more
Summaries of recent Fred Hutch research findings and other news
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
Trio of studies to evaluate metastatic breast cancer care
Hutch researcher awarded grants to study the use of biopsy to drive therapy choices and test new type of PET scan to stage lobular
Preventing brain metastasis in breast cancer
New $2.4M NCI grant funds research aimed at preventing disseminated tumor cells in the brain from waking up
Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer
Researchers ‘shocked’ to see how often experts misdiagnose certain brain tumors in kids
New study: Molecular tests reveal critical differences in cancers thought to be the same, highlight implications for treatment